Chemical and Biological Defense for US Forces
Item Details
Title
Chemical and Biological Defense for US Forces
Topics
The Subcommittees on Military Procurement and on Military Research and Development met to discuss the threat posed to US forces by chemical and biological weapons proliferation and their ability to fight on the battlefield under the threat of their use.
Date
1999
Conclusions
Further research and development is needed in broad-spectrum treatments for biological agents as mass vaccination is not feasible or practical when there is such a range of agents for an enemy to choose from. However, the anthrax vaccine could offer protection to troops from the most probable agent. There is also serious concern about the spread of biological weapons capabilities following the dissolution of the Soviet Union and Biopreparat.
Files
Source
United States House of Representatives Military Procurement Subcommittee and Military Research and Development Subcommittee of the Committee on Armed Services. Chemical and Biological Defense for U.S. Forces, Joint Hearing Before the Committee on Armed Services. US Government Printing Office. 1999.
Citation
“Chemical and Biological Defense for US Forces,” Collection of Biothreat Risk Assessments (COBRA), accessed January 15, 2025, https://cobrabiosecurity.org/items/show/464.